SCHEMBL9928265

SCHEMBL9928265

CCNc1ncnc2[nH]cc(CO)c12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IRAK4 Q9NWZ3 5/20 0.47
STK3 Q13188 5/20 0.47
PRKD3 O94806 5/20 0.47
MAP4K4 O95819 5/20 0.47
PRKACA P17612 5/20 0.47
CLK2 P49760 5/20 0.47
GSK3A P49840 5/20 0.47
GSK3B P49841 5/20 0.47
CDK5 Q00535 5/20 0.47
MAP4K2 Q12851 5/20 0.47
DYRK1A Q13627 5/20 0.47
CLK4 Q9HAZ1 4/20 0.47
ROCK2 O75116 4/20 0.47
CDK1 P06493 4/20 0.47
FGFR1 P11362 4/20 0.47
PHKG2 P15735 4/20 0.47
RPS6KB1 P23443 4/20 0.47
CDK2 P24941 4/20 0.47
MARK3 P27448 4/20 0.47
FLT4 P35916 4/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9928266 0.87 IRAK4 (0.54) IRAK4STK3PRKD3MAP4K4PRKACA
SCHEMBL9928270 0.74 ALOX15 (0.41) IRAK4STK3PRKD3MAP4K4PRKACA
SCHEMBL9928268 0.74 IRAK4 (0.43) IRAK4ROCK2JAK3ROCK1
SCHEMBL3236479 0.73 CHEK1 (0.56) IRAK4STK3PRKD3MAP4K4PRKACA
SCHEMBL22524312 0.73 IRAK4 (0.51) IRAK4STK3PRKD3MAP4K4PRKACA
SCHEMBL9928271 0.70 LRRK2 (0.36) IRAK4STK3JAK3LRRK2STK4
SCHEMBL9928278 0.69 EGFR (0.58) CDK1LCK
SCHEMBL22524207 0.68 IRAK4 (0.46) IRAK4STK3PRKD3MAP4K4PRKACA
SCHEMBL9928276 0.67 EGFR (0.52) DYRK1AFGFR1RPS6KB1AURKA
SCHEMBL9898706 0.67 CDC7 (0.43) IRAK4STK3PRKD3MAP4K4PRKACA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120149902-A1 PYRROLO[2,3-D]PYRIMIDINE DERIVATIVE UBE INDUSTRIES, LTD. (JP) 2012-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120149902-A1 PYRROLO[2,3-D]PYRIMIDINE DERIVATIVE ERBB2, EGFR, FGFR1 IRAK4 1112/4885STK3 139/4885PRKD3 509/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.